Adjunctive Cannabidiol for Drug-Resistant Epilepsy: A Systematic Review and Meta-Analysis of Randomized Trials Across Syndromes, Formulations, and Dose Ranges
Therapeutics and Clinical Risk Management · 2026-05 · Volume 22 · 1-14
DOI: 10.2147/tcrm.s601774 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Therapeutics and Clinical Risk Management, 2026-05. Verfasst von Reza Pratama und 3 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral Program, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Doctoral Program, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia.
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Bhakti Kencana, Bandung, 40614, Indonesia.
- Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia.
- Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia.
- Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang, 45363, Indonesia.
ORCID-Profile: Reza Pratama, Muhaimin Muhaimin, Miski Aghnia Khairinisa, Anis Yohana Chaerunisaa
Zitieren
APA
Pratama, R., Muhaimin, M., Khairinisa, M. A., & Chaerunisaa, A. Y. (2026). Adjunctive Cannabidiol for Drug-Resistant Epilepsy: A Systematic Review and Meta-Analysis of Randomized Trials Across Syndromes, Formulations, and Dose Ranges. Therapeutics and Clinical Risk Management, Volume 22, 1-14. https://doi.org/10.2147/tcrm.s601774
Vancouver
Pratama R, Muhaimin M, Khairinisa MA, Chaerunisaa AY. Adjunctive Cannabidiol for Drug-Resistant Epilepsy: A Systematic Review and Meta-Analysis of Randomized Trials Across Syndromes, Formulations, and Dose Ranges. Therapeutics and Clinical Risk Management. 2026;Volume 22:1-14. doi:10.2147/tcrm.s601774
BibTeX
@article{Pratama2026,
author = {Pratama, Reza and Muhaimin, Muhaimin and Khairinisa, Miski Aghnia and Chaerunisaa, Anis Yohana},
title = {Adjunctive Cannabidiol for Drug-Resistant Epilepsy: A Systematic Review and Meta-Analysis of Randomized Trials Across Syndromes, Formulations, and Dose Ranges},
journal = {Therapeutics and Clinical Risk Management},
year = {2026},
volume = {Volume 22},
pages = {1--14},
doi = {10.2147/tcrm.s601774}
}
EUVIMED